Recall record at a glance
| Official record | F-0761-2025 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | JJWV Marketing Corporation |
| Report date | May 14, 2025 |
| Recall initiation date | Apr 21, 2025 |
| Quantity | 346 cases from lot 2026 and 0 cases from lot 2027 |
| Location | Santa Fe Springs, CA, United States |
Official product description
Ankimo branded Monkfish Liver; NET WT. 7 OZ (200g); Imported and DIST. BY: JJWV Marketing Corporation; Santa Fe Springs, CA 90670 USA; UPC# 8 94042 00256 2
Why the product was recalled
Undeclared allergen ingredient (milk)
Distribution information
see attached distribution document. All California direct consignees. Have not determine if product was distributed out of state.
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.